| Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ... Jama 316 (2), 171-181, 2016 | 1699 | 2016 |
| Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 MS Cohen, IF Hoffman, RA Royce, P Kazembe, JR Dyer, CC Daly, ... The Lancet 349 (9069), 1868-1873, 1997 | 1119 | 1997 |
| Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study B Ledergerber, M Egger, M Opravil, A Telenti, B Hirschel, M Battegay, ... The Lancet 353 (9156), 863-868, 1999 | 1114 | 1999 |
| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1026 | 2019 |
| Brief but efficient: acute HIV infection and the sexual transmission of HIV CD Pilcher, HC Tien, JJ Eron, PL Vernazza, SY Leu, PW Stewart, LE Goh, ... Journal of infectious diseases 189 (10), 1785-1792, 2004 | 934 | 2004 |
| Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study J Fellay, C Marzolini, ER Meaden, DJ Back, T Buclin, JP Chave, ... The Lancet 359 (9300), 30-36, 2002 | 848 | 2002 |
| Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study M Egger, B Hirschel, P Francioli, P Sudre, M Wirz, M Flepp, M Rickenbach, ... Bmj 315 (7117), 1194-1199, 1997 | 772 | 1997 |
| AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study B Ledergerber, M Egger, V Erard, R Weber, B Hirschel, H Furrer, ... Jama 282 (23), 2220-2226, 1999 | 626 | 1999 |
| CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study GR Kaufmann, L Perrin, G Pantaleo, M Opravil, H Furrer, A Telenti, ... Archives of internal medicine 163 (18), 2187-2195, 2003 | 561 | 2003 |
| Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study J Fellay, B Ledergerber, E Bernasconi, H Furrer, M Battegay, B Hirschel, ... The Lancet 358 (9290), 1322-1327, 2001 | 484 | 2001 |
| Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle P Vernazza, B Hirschel, E Bernasconi, M Flepp Bulletin des médecins suisses| Schweizerische Ärztezeitung| Bollettino dei …, 2008 | 477 | 2008 |
| Characteristics, Determinants, and clinical relevance of CD4 T cell recovery to< 500 cells/µL in HIV type 1—infected individuals receiving potent antiretroviral therapy GR Kaufmann, H Furrer, B Ledergerber, L Perrin, M Opravil, P Vernazza, ... Clinical infectious diseases 41 (3), 361-372, 2005 | 433 | 2005 |
| Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model H Chakraborty, PK Sen, RW Helms, PL Vernazza, SA Fiscus, JJ Eron, ... Aids 15 (5), 621-627, 2001 | 406 | 2001 |
| HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load AN Phillips, S Staszewski, R Weber, O Kirk, P Francioli, V Miller, ... Jama 286 (20), 2560-2567, 2001 | 384 | 2001 |
| Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV PL Vernazza, L Troiani, MJ Flepp, RW Cone, J Schock, F Roth, K Boggian, ... Aids 14 (2), 117-121, 2000 | 378 | 2000 |
| Discontinuation of Primary Prophylaxis against Pneumocystis carinii Pneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy H Furrer, M Egger, M Opravil, E Bernasconi, B Hirschel, M Battegay, ... New England Journal of Medicine 340 (17), 1301-1306, 1999 | 355 | 1999 |
| Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades J Levi, A Raymond, A Pozniak, P Vernazza, P Kohler, A Hill BMJ global health 1 (2), e000010, 2016 | 351 | 2016 |
| HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study A Rodger, T Bruun, V Cambiano, P Vernazza, V Estrada, J Van Lunzen, ... Conference on Retroviruses and Opportunistic Infections, 3-6, 2014 | 346 | 2014 |
| Acute HIV infection: impact on the spread of HIV and transmission of drug resistance S Yerly, S Vora, P Rizzardi, JP Chave, PL Vernazza, M Flepp, A Telenti, ... Aids 15 (17), 2287-2292, 2001 | 307 | 2001 |
| Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study A Rauch, M Martin, R Weber, B Hirschel, PE Tarr, HC Bucher, P Vernazza, ... Clinical infectious diseases 41 (3), 395-402, 2005 | 293 | 2005 |
